Cash & equivalents increased 281.1%
Cash & equivalents changed +281.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +281.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Current assets changed +213.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Research & development changed +21.1% from the comparable as-filed period.
Capital expenditure changed -39.1% from the comparable as-filed period.
Stock-based compensation changed +18.1% from the comparable as-filed period.
Current liabilities changed +5.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.